Hereditary Cancer Syndrome Testing

This dataset provides detailed records of hereditary cancer syndrome genetic testing, including patient demographics, test results for key genes (such as BRCA1/2, Lynch syndrome, TP53, PTEN), risk assessments, and recommendations for cascade testing. It enables robust analysis of genetic risk, variant prevalence, and clinical follow-up, supporting precision medicine and family-based cancer prevention strategies.

  • last updated 2 Nov 2025
  • by GoMask
The brief that made it

Clinical decision support for hereditary cancer risk management

Sample rows

preview · 8 of 100 rows · all 26 columns
test_idstringrisk_assessment_categorystringrisk_assessment_scorefloatfamily_history_cancerbooleanvariant_genestringpatient_idstringpatient_first_namestringpatient_last_namestringpatient_date_of_birthdatepatient_genderstringpatient_ethnicitystringpersonal_history_cancerbooleantest_datedatetest_typestringgenes_testedstringpathogenic_variant_detectedbooleanvariant_descriptionstringvariant_classificationstringcascade_testing_recommendedbooleancascade_testing_completedbooleanreferring_physician_idstringreferring_physician_namestringinstitution_namestringinstitution_citystringinstitution_statestringinstitution_countrystring
TEST00001low1.3trueblankPAT1001JenniferMiller1974-08-15femaleWhitefalse2022-09-13BRCA1/2BRCA1,BRCA2falseblanknot detectedfalseblankPHY3001Dr. Rachel FordMidwest Oncology CenterChicagoILUSA
TEST00002high7.5trueMSH2PAT1002SamuelNguyen1968-03-23maleAsiantrue2023-03-16Lynch syndromeMLH1,MSH2,MSH6,PMS2,EPCAMtruec.942+3A>TpathogenictruefalsePHY3021Dr. Kevin LeePacific Genetics ClinicSan FranciscoCAUSA
TEST00003low0.9falseblankPAT1003MariaSantos1980-11-27femaleHispanicfalse2023-01-08BRCA1/2BRCA1,BRCA2falseblanknot detectedfalseblankPHY3032Dr. Jorge RamirezSunrise Medical CenterPhoenixAZUSA
TEST00004high5.8trueTP53PAT1004JamesCarter1955-05-12maleBlacktrue2022-10-05TP53TP53truec.818G>A (p.Arg273His)likely pathogenictruetruePHY3017Dr. Linda BrooksEastern Cancer InstituteAtlantaGAUSA
TEST00005moderate2.6trueblankPAT1005HarpreetSingh1990-07-19femaleSouth Asianfalse2023-02-14PTENPTENfalseblanknot detectedfalseblankPHY3045Dr. Amit PatelNorthern Molecular LabSeattleWAUSA
TEST00006low0.6falseblankPAT1006OliviaBrown2002-06-01femaleWhitefalse2022-06-26OtherATM,CHEK2falseblankbenignfalseblankPHY3015Dr. Steven HallMetro Genetics CenterDenverCOUSA
TEST00007high8.2trueBRCA2PAT1007DianaWilson1987-02-13femaleWhitetrue2022-12-02BRCA1/2BRCA1,BRCA2truec.5946delT (p.Ser1982fs)pathogenictruetruePHY3051Dr. Emily HarrisCentral Oncology GroupDallasTXUSA
TEST00008low1.1falseblankPAT1008RobertJohnson1971-11-05maleBlackfalse2023-04-11Lynch syndromeMLH1,MSH2,MSH6,PMS2,EPCAMfalseblanknot detectedfalseblankPHY3058Dr. Henry WhiteWestern Genetics ClinicLos AngelesCAUSA

What the 100 rows show

from the 100-row sample

High (risk assessment category) stands out: mean risk_assessment_score is 7.7, against 1.7 for the rest.

  • 54%family_history_cancer = true
  • 1.9median risk_assessment_score
  • 3patient genders
  • 4institution countries
  • 5test types
  • 6variant classifications
Mean risk_assessment_score by risk_assessment_category100 rows
0487.7high25 rows2.6moderate21 rows1.3low53 rows1.0unknown1 rows
risk_assessment_score100 rows, in bands of 1
0204011402040159820510risk_assessment_score →

Median 1.9, from 0.50 to 9.2.

variant_gene25 rows with a value · 75 left blank
  1. BRCA27
  2. BRCA15
  3. TP534
  4. MSH23
  5. PTEN2
  6. MSH62
  7. PMS21
  8. MLH11
26 columns by typefrom the column list below
  • string 18
  • float 1
  • date 2
  • boolean 5

Columns

26 columns in four groups
blueprint · 26 columns
columntypedescriptionexample
Text 18 columns
test_idstringUnique identifier for each genetic test performeduniqueTEST00001
patient_idstringUnique identifier for the patient undergoing testingPAT1001
patient_first_namestringPatient's first nameJennifer
patient_last_namestringPatient's last nameMiller
patient_genderstringPatient's gendermale · female · other · unknownfemale
patient_ethnicitystringPatient's self-reported ethnicityoptionalWhite
test_typestringType of hereditary cancer syndrome test performedBRCA1/2 · Lynch syndrome · TP53 · PTEN · OtherBRCA1/2
genes_testedstringComma-separated list of genes tested in this panelBRCA1,BRCA2
variant_genestringGene in which the pathogenic variant was detected (if any)8 genes · optionalMSH2
variant_descriptionstringDescription of the detected variant (HGVS nomenclature or similar)optionalc.942+3A>T
variant_classificationstringClassification of the variant (e.g., pathogenic, likely pathogenic, VUS, benign)6 values · optionalnot detected
risk_assessment_categorystringCategorical risk assessment (e.g., high, moderate, low)high · moderate · low · unknown · optionallow
referring_physician_idstringUnique identifier for the referring physicianoptionalPHY3001
referring_physician_namestringName of the referring physicianoptionalDr. Rachel Ford
institution_namestringName of the institution where testing was performedoptionalMidwest Oncology Center
institution_citystringCity of the institutionoptionalChicago
institution_statestringState/province of the institutionoptionalIL
institution_countrystringCountry of the institution4 countries · optionalUSA
Numbers 1 column
risk_assessment_scorefloatQuantitative risk assessment score for hereditary cancer (if available)0 or more · optional1.3
Dates and times 2 columns
patient_date_of_birthdatePatient's date of birth1974-08-15
test_datedateDate when the genetic test was performed2022-09-13
True or false 5 columns
family_history_cancerbooleanIndicates if the patient has a family history of cancertrue
personal_history_cancerbooleanIndicates if the patient has a personal history of cancerfalse
pathogenic_variant_detectedbooleanIndicates if a pathogenic variant was detectedfalse
cascade_testing_recommendedbooleanIndicates if cascade testing is recommended for family membersfalse
cascade_testing_completedbooleanIndicates if cascade testing has been completed for family membersoptionalfalse

Use it for

  • family history…54%54 of 100 rowsmean risk assessment …7.7high2.6mode…1.3low1.0unkn…

    A healthcare dashboard

    The family_history_cancer rate, risk_assessment_score by risk_assessment_category and a breakdown of variant_gene. Excel, Power BI or Tableau.

  • Why do the 25 high rows have a mean risk_assessment_score of 7.7?

    A root-cause class exercise

    Hand out the rows and one question. The answer is in the data, not in the brief.

  • A software demo

    Believable tests with patient_id, patient_first_name and patient_last_name to fill a screen in front of a buyer.

Not quite right?

Make it yours.

Same 26 columns, your size and your rules. See 20 rows before you pay.

Preview 20 rows free

1,000 rows: $1.99 · 10,000: $12.99One-time. No subscription. All prices

This dataset100 rows26 columns
Yours1,000 rows26 columnsinstitution_city: UK only

blueprint · hereditary-cancer-syndrome-testing

Behind this dataset

Same schema. As many rows as you need.

These 100 rows came out of a blueprint — 26 columns with generation rules behind each one. Open it in Data Factory to retune a column, add your own, wire in foreign keys, and run it at the size you actually need.

Rules it was built with
  • Test ID unique per individual
  • Genes tested: BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, EPCAM, TP53, PTEN, etc.
  • Indication: personal cancer history, family history, Ashkenazi ancestry
  • Pathogenic variant identified or negative
  • Variant of uncertain significance (VUS)
  • Cancer risk estimates for carriers
  • BRCA1/2: breast, ovarian, prostate, pancreatic cancer risk
  • Lynch syndrome: colorectal, endometrial, gastric, ovarian cancer risk
Rows
Open the blueprint in Data Factory

1 credit per row. Preview 20 rows free. Buy rows for the full run.

Exports
CSV, JSON, JSONL, Parquet, SQL, Excel, TSV, XML
Licence
yours to use, including commercially
API slug
hereditary-cancer-syndrome-testing

What should your data show?

Preview 20 rows free
No signup. No card.